InSilico Medicine
Insilico Medicine is an AI-driven drug discovery and development company that uses deep learning and generative models to identify novel therapeutic targets and design small-molecule drug candidates for pharmaceutical and biotech partners. It offers a proprietary discovery platform and advances its own internal pipeline, generating revenue through research collaborations, licensing, and milestone-based agreements. The company focuses on areas such as fibrosis, oncology, and age-related diseases.
- MLOps & ML Platforms
- Clinical Trial & Research Software
- Revenue
- $35.0M
- Employees
- 330
- Founded
- 2014
- Headquarters
- South San Francisco, United States of America
What 7 Arbolus experts think of InSilico Medicine
NPS scores are concentrated between 6 and 10, with four responses above 8 and three at 7. Overall weighted NPS is moderately positive. Among high spenders, NPS is 7–8, but renewal intent is mixed: many are unsure or negative. Platform stickiness is strong among Users and longer-term customers, with 75% of experts reporting implementation for more than one year. Key theme: while user satisfaction is high, renewal uncertainty among high-value accounts tempers overall sentiment.Overall Customer Sentiment: Neutral
Who reviewed InSilico Medicine
- C-Suite 57% (4)
- Director 43% (3)
Employer names and spend open once the report publishes.
Tell us when the InSilico Medicine report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
28 Net Promoter Score, from 7 scored reviews- Promoters 3
- Passives 3
- Detractors 1
Cumulative NPS by month
-1 over 3 months- Jun 9
- Jul 9
- Sep 8
Net Promoter Score across 1 reviews, accumulated up to each month. Category median 28 across 1 companies.
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 33%Plan to renew, by seniority
- 0% 1 answer
- 50% 2 answers
- 10/10 Average score from customers who will renew
- 7/10 Average score from undecided customers
- 6/10 Average score from customers not renewing
More in Data & Analytics and AI Tools
Other companies in both categories with a customer report.
For people who use InSilico Medicine
Do you use InSilico Medicine at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 7 customers of InSilico Medicine have already contributed
Takes a few minutes. Your identity stays anonymous.